PubMed · 2026-02-26
Scientists are now engineering the starch inside crop plants with surgical precision — tweaking which enzymes build it, how branched it is, and how fast your body digests it — to create foods that spike blood sugar less and bioplastics that don't depend on petroleum.
CRISPR-Cas genome editing can generate high-amylose, low-glycemic staple crops without inserting foreign DNA, making regulatory approval simpler than traditional GMO approaches.
The ratio of amylose to amylopectin and the distribution of chain lengths in starch directly control how fast it digests, how it behaves in cooking, and how much 'resistant starch' reaches the gut microbiome.
Cell-free synthetic biology platforms — essentially starch-building enzyme systems run outside any living cell — can produce highly pure, structurally defined starches for both food and bioplastic applications with greater reproducibility than plant-based production.
